KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $14.9 billion.

  • Thermo Fisher Scientific's Total Current Liabilities rose 196.56% to $14.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 billion, marking a year-over-year increase of 196.56%. This contributed to the annual value of $13.3 billion for FY2024, which is 485.3% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Total Current Liabilities stood at $14.9 billion for Q3 2025, which was up 196.56% from $12.7 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year Total Current Liabilities high stood at $17.0 billion for Q4 2022, and its period low was $6.9 billion during Q3 2021.
  • Its 5-year average for Total Current Liabilities is $12.7 billion, with a median of $13.4 billion in 2021.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 7255.18% in 2022, then tumbled by 1762.49% in 2023.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Total Current Liabilities stood at $13.4 billion in 2021, then grew by 26.6% to $17.0 billion in 2022, then dropped by 17.62% to $14.0 billion in 2023, then decreased by 4.85% to $13.3 billion in 2024, then rose by 11.67% to $14.9 billion in 2025.
  • Its Total Current Liabilities stands at $14.9 billion for Q3 2025, versus $12.7 billion for Q2 2025 and $13.2 billion for Q1 2025.